Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction

Journal of Proteome Research

Volumn 2, Issue 4, 2003, Pages 361-372

  Marshall, John ^a,b   Kupchak, Peter ^a   Zhu, Weimin ^a   Yantha, Jason ^a   Vrees, Tammy ^a   Furesz, Shirley ^a   Jacks, Kellie ^a   Smith, Chris ^a   Kireeva, Inga ^a   Zhang, Rulin ^a   Takahashi, Miyoko ^a   Stanton, Eric ^a   Jackowski, George ^a  

^a Syn X Pharma Inc   (Canada)

^b RYERSON UNIVERSITY   (Canada)

Author keywords

Complement C3f; Diagnostic; Fibrinogen alpha peptide; Mass spectrometry; Myocardial infarction; Sera

Indexed keywords

AMINOPEPTIDASE; COMPLEMENT COMPONENT C3; FIBRINOGEN; PEPTIDE; PLASMA PROTEIN;

ALPHA CHAIN; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; HEART INFARCTION; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEOMICS; SERUM; TIME;

AMINO ACID SEQUENCE; ANALYSIS OF VARIANCE; AUTOMATIC DATA PROCESSING; BLOOD PROTEINS; BLOTTING, WESTERN; COMPLEMENT C3; COMPLEMENT C3B; COMPUTATIONAL BIOLOGY; DATA INTERPRETATION, STATISTICAL; DATABASES, GENETIC; FIBRINOGEN; HUMANS; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PEPTIDE HYDROLASES; PEPTIDE MAPPING; PHENYLMETHYLSULFONYL FLUORIDE; PROTEASE INHIBITORS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

EID: 12444330378     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr030003l     Document Type: Article

References (52)

1. Ardekani, A. M.; Liotta, L. A.; Petricoin, E. F., 3rd Clinical potential of proteomics in the diagnosis of ovarian cancer. Expert Rev. Mol. Diagn. 2002, 2 (4), 312-320
2. Uchida, T.; Fukawa, A.; Uchida, M.; Kyosuke, F.; Saito, K. Application of a Novel Protein Biochip for Detection and Identification of a Rheumatoid Arthritis Biomarkers in Synovial Fluid. J. Proteome Res. 2002, 1, 495-499.
3. Paweletz, C. P.; Trock, B.; Pennanen, M.; Tsangaris, T.; Magnant, C.; Liotta, L. A.; Petricoin, E. F., 3rd Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis. Markers 2001, 17 (4), 301-307.
4. Weinberger, S. R.; Morris, T. S.; Pawlak, M. Recent trends in protein biochip technology. Pharmacogenomics 2000, 1(4), 395-416.
5. Oleschuk, R. D.; McComb, M. E.; Chow, A.; Ens, W.; Standing, K. G.; Perreault, H.; Marois, Y.; King, M. Characterization of plasma proteins adsorbed onto biomaterials. By MALDI-TOFMS. Biomaterials 2000, 21(16), 1701-1710.
6. Wright, G. L., Jr. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis. Expert Rev. Mol. Diagn. 2002, 2(6), 549-563.
7. Ball, G.; Oleschuk, R. D.; McComb, M. E.; Chow, A.; Ens, W.; Standing, K. G.; Perreault, H.; Marois, Y.; King, M. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics 2002, 18(3), 395-404.
8. Qu, Y.; Adam, B. L.; Yasui, Y.; Ward, M. D.; Cazares, L. H.; Schellhammer, P. F.; Feng, Z.; Semmes, O. J.; Wright, G. L., Jr. Boosted Decision Tree Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles Discriminates Prostate Cancer from Noncancer Patients. Clin. Chem. 2002, 48(10), 1835-1843.
9. Fenn, J. B.; Mann, M.; Meng, C. K.; Wong, S. F.; Whitehouse, C. M. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989, 246(4926), 64-71.
10. Nakanishi, T.; Okamoto, N.; Tanaka, K.; Shimizu, A. Laser desorption time-of-flight mass spectrometric analysis of transferrin precipitated with antiserum: a unique simple method to identify molecular weight variants. Biol. Mass Spectrom 1994, 23(4), 230-233.
11. DeHoffmann, E.; Stroobant, V. Mass Spectrometry Principles and Applications, 3rd ed.; John Wiley and Sons: New York, 2001.
12. Griffin, T. J.; Gygi, S. P.; Rist, B.; Aebersold, R.; Loboda, A.; Jilkine, A.; Ens, W.; Standing, K. G. Quantitative proteomic analysis using a MALDI quadrupole time-of-flight mass spectrometer. Anal. Chem, 2001, 73(5), 978-986.
13. Loboda, A. V.; Krutchinsky, A. N.; Bromirski, M.; Ens, W.; Standing, K. G. A tandem quadrupole/time-of-flight mass spectrometer with a matrix- assisted laser desorption/ionization source: design and performance. Rapid Commun. Mass Spectrom. 2000, 14(12), 1047-1057.
14. Shevchenko, A.; Loboda, A.; Ens, W.; Standing, K. G. MALDI quadrupole time-of-flight mass spectrometry: a powerful tool for proteomic research. Anal. Chem. 2000, 72(9), 2132-2141.
15. Verhaert, P.; Uttenweiler-Joseph, S.; de Vries, M.; Loboda, A.; Ens, W.; Standing, K. G. Matrix-assisted laser desorption/ionization quadrupole time-of-flight mass spectrometry: an elegant tool for peptidomics. Proteomics 2001, 1(1), 118-131.
16. Shevchenko, A.; Chernushevich, I.; Ens, W.; Standing, K. G.; Thomson, B. ; Wilm, M.; Mann, M. Rapid 'de novo' peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom. 1997, 11(9), 1015-1024.
17. Stafford, G. C.; Kelley, P. E.; Syka, J. E.; Kelley, P. E.; Syka, J. E.; Reynolds, W. E.; Todd, J. F. J. Recent improvement and applications of advanced ion trap technology. Int. J. Mass Spectrom. Ion Proc. 1984, 60, 85.
18. Qian, M. G.; Lubman, D. M. Analysis of tryptic digests using microbore HPLC with an ion trap storage/reflectron time-of-flight detector. Anal. Chem. 1995, 67(17), 2870-2877.
19. Link, A. J.; Eng, J.; Schieltz, D. M.; Carmack, E.; Mize, G. J,; Morris, D. R.; Garvik, B. M.; Yates, J. R., 3rd Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 1999, 17(7), 676-82.
20. Mann, M,; Hendrickson, R. C.; Pandey, A. Analysis of proteins and proteomes by mass spectrometry. Annu. Rev. Biochem. 2001, 70, 437-473.
21. Rogers, B. A.; Newby, L. K. New biomarkers in the risk stratification of patients with suspected acute myocardial infarction. Curr. Cardiol. Rep. 2002, 4(4), 341-347.
22. Azzazy, H. M.; Christenson, R. H. Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing? Clin. Biochem. 2002, 35(1), 13-27.
23. Ellestad, M. H.; Startt-Selvester, R.; Stanton, E.; VanNatta, B.; Ahmad, J.; Gawad, Y.; Swiger, F. The utility of four biochemical markers in the triage of chest pain patients. Cardiology 2000, 93(4), 242-248.
24. Douketis, J. D.; Crowther, M. A.; Stanton, E. B.; Ginsberg, J. S. Elevated cardiac troponin levels in patients with submassive pulmonary embolism. Arch. Intern. Med. 2002, 162(1), 79-81.
25. Frangogiannis, N. G.; Smith, C. W.; Entman, M. L. The inflammatory response in myocardial infarction. Cardiovasc. Res. 2002, 53(1), 31-47.
26. Sahu, A.; Lambris, J. D. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev. 2001, 180, 35-48.
27. Nielsen, C. H.; Leslie, R. G. Complement's participation in acquired immunity. J. Leukocyte Biol. 2002, 72(2), 249-261.
28. Krzanowski, W. J.; Marriott, F. H. C. Multivariate Analyses Part 2: Classification, Covariance Structures and Repeated Measurements; Arnold: London, 1995.
29. Chu, I. K.; Cox, D. M.; Guo, X.; Kireeva, I.; Lau, T. C.; McDermott, J. C.; Siu, K. W. Sequencing of argentinated peptides by means of matrix-assisted laser desorption/ionization tandem mass spectrometry. Anal. Chem. 2002, 74(9), 2072-2082.
30. Kottis, V.; Thibault, P.; Mikol, D.; Xiao, Z. C.; Zhang, R.; Dergham, P. ; Braun, P. E. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem. 2002, 82(6), 1566-1569.
31. Yates, J. R., 3rd.; Eng, J. K.; McCormack, A. L.; Schieltz, D. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 1995, 67(8), 1426-1436.
32. Washburn, M. P.; Wolters, D.; Yates, J. R. 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19(3), 242-247.
33. Schagger, H.; von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 1987, 166(2), 368-379.
34. Towbin, H.; Staehelin, T.; Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 1979, 76(9), 4350-4354.
35. Fung, E. T.; Enderwick, C. ProteinChip clinical proteomics: computational challenges and solutions. Biotechniques 2002, Suppl: p 34-8, 40-1.
36. Li, J.; Zhang, Z.; Rosenzweig, J.; Wang, Y. Y.; Chan, D. W. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 2002, 48(8), 1296-1304.
37. Volanakis, J. E. Participation of C3 and its ligands in complement activation. Curr. Top Microbiol. Immunol. 1990, 153, 1-21.
38. Fishelson, Z. Complement C3: a molecular mosaic of binding sites. Mol. Immunol. 1991, 28(4-5), 545-552.
39. Sanderink, G. J.; Artur, Y.; Siest, G. Human aminopeptidases: a review of the literature. J. Clin. Chem. Clin. Biochem. 1988, 26(12), 795-807.
40. Merchant, M.; Weinberger, S. R. Recent advancements in surface-enhanced laser desorption/ionization-time-of-flight-mass spectrometry. Electrophoresis 2000, 21(6), 1164-1177.
41. Hanash, S.; Celis, J. E. The human proteome organization: a mission to advance proteome knowledge. Mol. Cell Proteomics 2002, 1(6), 413-414.
42. Fareed, J.; Hoppensteadt, D. A.; Leya, F.; Iqbal, O.; Wolf, H.; Bick, R. Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes. Clin. Chem. 1998, 44(8 Pt 2), 1845-1853.
43. Yasojima, K.; Schwab, C.; McGeer, E. G.; McGeer, P. L Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ. Res. 1998. 83(8), 860-869.
44. Vakeva, A. P.; Agah, A.; Rollins, S. A.; Matis, L. A.; Li, L.; Stahl, G. L. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 1998, 97(22), 2259-2267.
45. Birdsall, H. H.; Green, D. M.; Trial, J.; Youker, K. A.; Burns, A. R.; MacKay, C. R.; LaRosa, G. J.; Hawkins, H. K.; Smith, C. W.; Michael, L. H.; Entman, M. L.; Rossen, R. D. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to 5 h after reperfusion. Circulation 1997, 95(3), 684-692.
46. Dreyer, W. J.; Michael, L. H.; Nguyen, T.; Smith, C. W.; Anderson, D. C. ; Entman, M. L.; Rossen, R. D. Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. Circ. Res. 1992, 71(6), 1518-1524.
47. Maroko, P. R.; Carpenter, C. B.; Chiariello, M.; Fishbein, M. C.; Radvany, P.; Knostman, J. D.; Hale, S. L. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J. Clin. Invest. 1978, 61(3), 661-670.
48. Weisman, H. F.; Bartow, T.; Leppo, M. K.; Marsh, H. C., Jr.; Carson, G. R.; Concino, M. F.; Boyle, M. P.; Roux, K. H.; Weisfeldt, M. L.; Fearon, D. T. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990, 249(4965), 146-151.
49. Weisman, H. F.; Bartow, T.; Leppo, M. K.; Boyle, M. P.; Marsh, H. C., Jr.; Carson, G. R.; Roux, K. H.; Weisfeldt, M. L.; Fearon, D. T. Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium. Trans Assoc. Am. Physicians 1990, 103, 64-72.
50. Eisenberg, P. R.; Sherman, L. A.; Schectman, K.; Perez, J.; Sobel, B. E. ; Jaffe, A. S. Fibrinopeptide A: a marker of acute coronary thrombosis. Circulation 1985, 71(5), 912-918.
51. Kockum, C.; Frebelius, S. Rapid radioimmunoassay of human fibrinopeptide A - removal of cross- reacting fibrinogen with bentonite. Thromb Res. 1980, 19(4-5), 589-598.
52. Lee, L. V.; Ewald, G. A.; McKenzie, C. R.; Eisenberg, P. R. The relationship of soluble fibrin and cross-linked fibrin degradation products to the clinical course of myocardial infarction. Arterioscler Thromb Vasc. Biol. 1997, 17(4), 628-633.